# Johns Hopkins Bloomberg School of Public Health

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/johns-hopkins-bloomberg-school-of-public-health
Canonical HTML page: https://getyourbrief.com/entity/johns-hopkins-bloomberg-school-of-public-health

## Timeline

- **2026-09-09**: Experts assess the 2026–27 flu season outlook — NBC stations publish expert outlook citing CDC data and Australia's moderate 2026 season as early signals for the U.S.
- **2026**: Scientists update 2026–27 flu vaccines for subclade K strain — Vaccine composition is updated earlier in 2026 to protect against the subclade K influenza strain.
- **2025**: Australia records busiest, deadliest flu season in decades — Australia's 2025 Southern Hemisphere flu season becomes the country's busiest and deadliest in decades, later used as the comparison baseline for 2026.

## Recent coverage (4 stories, network-wide)

### 2026-27 Flu Outlook: After a 25-Year Record Season, Early Signals
2026-09-09 23:22:49 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

After the 2025–26 season set a 25-year record for flu-like illness visits, health system leaders are parsing early signals — Australia's moderate 2026 season and the subclade K vaccine update — to gauge 2026–27 capacity, surveillance and forecasting needs.
Full story: https://gethealthbrief.com/story/2026-27-flu-season-outlook-health-it

### MMR Unbundling Could Add Millions of Syringes to U.S. Supply Chain
2026-08-13 15:52:09 · Sector: supply · Sentiment: Neutral · Impact: 6/10 · Sources: 2

Trump's order to split the MMR vaccine into individual shots threatens to reverse decades of pediatric vaccine bundling, forcing manufacturers and distributors to source millions more syringes, vials, and cold-chain shipments. Procurement teams and clinics face uncertain demand forecasts and rising consumables costs.
Full story: https://getsupplybrief.com/story/trump-vaccine-order-supply-chain-mmr-syringes

### Trump's 90-Day Vaccine Unbundling Plan Risks Lower Immunization Rates
2026-08-13 15:52:03 · Sector: health · Sentiment: Neutral · Impact: 6/10 · Sources: 2

Clinicians and public health officials warn the executive order to split the MMR vaccine and space out injections could reduce childhood immunization completion. Pediatric practices face more visits, more documentation, and higher costs with no clinical benefit identified.
Full story: https://gethealthbrief.com/story/trump-vaccine-unbundling-public-health-risk

### MMR Unbundling Would Cost Drugmakers Tens of Millions to Revive Old Shots
2026-08-13 15:51:55 · Sector: bio · Sentiment: Neutral · Impact: 6/10 · Sources: 2

Biopharma executives face a potential forced revival of discontinued single-antigen measles, mumps, and rubella vaccines, requiring new manufacturing lines and regulatory work. Analysts estimate tens of millions in upfront costs and years of development before any unbundled schedule could be supplied.
Full story: https://getbiobrief.com/story/mmr-unbundling-biopharma-regulatory-cost

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.